It was demonstrated that bladder cancer cells were sensitized to ferroptosis by p53 pharmacological activation or ALOX15B overexpression, whereas ALOX15B silencing had the opposite effect [181]. The gene discussed is TP53; the disease is urinary bladder cancer.